BRCA gene mutations can significantly raise a woman’s risk of breast and ovarian cancer. Know how hereditary cancer risk works and why genetic testing and early screening matter.

Colorectal cancer is often linked to lifestyle, but inherited gene mutations can also raise risk. Hereditary conditions like ...

Delayed parenthood intersects with important biological realities. Female fertility begins to decline gradually after the age of 32 and more sharply after 37. By age 40 the chance of natural ...

Marijuana extract shown to cut life-threatening seizures in half for children with severe epilepsy. A landmark clinical trial has revealed that a drug derived from medical marijuana can significantly ...

Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, ...

Zydus Lifesciences' subsidiary, Sentynl Therapeutics, has licensed the experimental molecule Progerinin to treat ...

RGX-121 was rejected in early February, with Regenxbio listing the primary reasons given by the FDA as concerns about the ability to properly define a patient population, the use of a natural history ...

Sentynl Therapeutics licenses Progerinin from PRG S&T for Hutchinson-Gilford Progeria Syndrome. Clinical trial data expected ...

March 16 (Reuters) - BioMarin Pharmaceutical will discontinue mid-stage trials of its bone disorder treatment after reports of several cases of patients' hip joint slipping out of place, the drugmaker ...

BioMarin will discontinue dosing and enrollment of its phase 2 trials for Voxzogo—currently approved in achondroplasia, a ...

The day we discovered that our then 15-month-old baby was one of just 200 people in the world with a genetic brain condition will be for ever etched on my mind.

Atrium is led by Kathleen Gallagher, who was chief programme officer at Avidity before it was acquired by Novartis and will ...